Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NuCapCure

Financiado

Development of innovative proton and neutron therapies with high cancer specific...

Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis. "Deep-lying cancers, such as glioblastoma multiforme (GBM) brain cancer, are very difficult to access and incurable by the current standards of care. The fluorescence of photosensitive molecules (PSs) can precisely guide surgical... ver más

31/07/2028

Innovasjon Norge

6M€

Presupuesto del proyecto: 6M€

Líder del proyecto

Innovasjon Norge No se ha especificado una descripción o un objeto social para esta compañía.

Ver 7 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-11-16

HORIZON-EIC-2023-PATHFINDEROPEN-01-01: EIC Pathfinder Open Scope:

I+D

Cerrada hace 1 año

0% 100%

7 Participantes

Innovasjon Norge

2.21M€ | Lider

CVR

596.65K€ | Participante

EURICE EUROPEAN RESEARCH AND...

422.50K€ | Participante

UNIVERSITAIR MEDISCH CENTRUM...

756.26K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Photochem-RS-RP Unraveling the Photochemistry of Radiosensitizers and Radiop... 231K€ Cerrado

GNVISION Gamma-Neutron Vision aimed at improved cancer treatments in... 150K€ Cerrado

PDC2022-133127-I00 UN PROTOTIPO DE DETECTOR DE RANGO PARA PROTON CT 125K€ Cerrado

HLPA High-quality Laser-driven Proton beams for multidisciplinary... 166K€ Cerrado

PDC2022-133605-I00 TELESCOPIO PARA CT DE PROTONES HA HADRONTERAPIA 115K€ Cerrado

RADIOBIO Deciphering the radiobiology of targeted radionuclide therap... 2M€ Cerrado

Duración del proyecto: 56 meses Fecha Inicio: 2023-11-16
Fecha Fin: 2028-07-31

Líder del proyecto

Innovasjon Norge No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 6M€

Descripción del proyecto "Deep-lying cancers, such as glioblastoma multiforme (GBM) brain cancer, are very difficult to access and incurable by the current standards of care. The fluorescence of photosensitive molecules (PSs) can precisely guide surgical resection of GBM. Nevertheless, photomedical treatments like photodynamic therapy (PDT) show limited efficacies due to the low penetration of light into tissue. Proton radiotherapy can reach deep-lying disease through therapeutic energy deposition in a spatially confined region called Bragg peak. Current neutron-based therapies, like Boron Neutron Capture Therapy (BNCT), have sufficient penetration depth but lack cancer specificity. In NuCapCure, we propose to 'hijack' intracellular biosynthetic pathways and use them to produce custom-made drugs that will facilitate two genuinely new cancer treatments: i) ""NuCapCure Proton"", combining proton radiotherapy, protondynamic therapy through PS proton activation, and proton capture therapy (BPCT) through three produced alpha particles; and ii) ""NuCapCure neutron"", combining GBM specific BNCT and PS neutron activation as demonstrated in our FET-open project FRINGE. The main scientific breakthroughs of NuCapCure will be to demonstrate the custom production of novel compounds through native intracellular biosynthesis but also to establish experimental proof-of-principle, both in vitro and in vivo, of the proposed two novel therapies. Our highly interdisciplinary project team comprises world-renowned experts from a unique combination of disciplines: proton and neutron physics, synthetic chemistry, photochemistry, photobiology, radiobiology, medical physics, nuclear reactor and particle accelerator technology and radio-oncology to lay the foundations for novel, targeted and curative therapies against currently fatal cancer indications like GBM."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores